ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell Therapy Manufacturing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-2V18388
Home | Market Reports | Health| Medical Facilities & Services
Global Cell Therapy Manufacturing Service Market Research Report 2024
BUY CHAPTERS

Global Cell Therapy Manufacturing Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-2V18388
Report
October 2025
Pages:144
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Charles River
Lonza
Catalent
Thermo Fisher Scientific
WuXi AppTech
KBI Biopharma
AGC Biologics
GenScript
3P Biopharmaceuticals
Siegfried
Minaris Regenerative Medicine
Bio-Techne

Cell Therapy Manufacturing Service Market

The global Cell Therapy Manufacturing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Cell Therapy Manufacturing Service is a professional service that covers the entire production process of cell therapy products, from cell collection, separation, culture, expansion to gene modification and quality control. These services support pharmaceutical companies, research institutions and medical institutions to develop and manufacture cell therapy products for the treatment of cancer, genetic diseases, immune diseases, etc.
With the clinical success of cell therapy technologies such as CAR-T cell therapy and stem cell therapy, the market demand for high-quality, large-scale manufacturing of cell therapy products has increased significantly. North America and Europe are currently the main markets, thanks to advanced medical technology and regulatory support, while the Asia-Pacific region, especially China and Japan, is becoming a new growth engine with the rapid development of the biopharmaceutical industry. It is expected that the market will continue to expand in the next few years to meet the growing global demand for cell therapy.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Cell Therapy Manufacturing Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Cell Therapy Manufacturing Service Market Report

Report Metric Details
Report Name Cell Therapy Manufacturing Service Market
Segment by Type
  • Autologous Cell Therapy Manufacturing Services
  • Allogeneic Cell Therapy Manufacturing Services
Segment by Application
  • Cancer Treatment
  • Regenerative Medicine
  • Genetic Disease Treatment
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, Lonza, Catalent, Thermo Fisher Scientific, WuXi AppTech, KBI Biopharma, AGC Biologics, GenScript, 3P Biopharmaceuticals, Siegfried, Minaris Regenerative Medicine, Bio-Techne
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Cell Therapy Manufacturing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Cell Therapy Manufacturing Service Market report?

Ans: The main players in the Cell Therapy Manufacturing Service Market are Charles River, Lonza, Catalent, Thermo Fisher Scientific, WuXi AppTech, KBI Biopharma, AGC Biologics, GenScript, 3P Biopharmaceuticals, Siegfried, Minaris Regenerative Medicine, Bio-Techne

What are the Application segmentation covered in the Cell Therapy Manufacturing Service Market report?

Ans: The Applications covered in the Cell Therapy Manufacturing Service Market report are Cancer Treatment, Regenerative Medicine, Genetic Disease Treatment, Others

What are the Type segmentation covered in the Cell Therapy Manufacturing Service Market report?

Ans: The Types covered in the Cell Therapy Manufacturing Service Market report are Autologous Cell Therapy Manufacturing Services, Allogeneic Cell Therapy Manufacturing Services

1 Study Coverage
1.1 Introduction to Cell Therapy Manufacturing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cell Therapy Manufacturing Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Autologous Cell Therapy Manufacturing Services
1.2.3 Allogeneic Cell Therapy Manufacturing Services
1.3 Market Segmentation by Application
1.3.1 Global Cell Therapy Manufacturing Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cancer Treatment
1.3.3 Regenerative Medicine
1.3.4 Genetic Disease Treatment
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cell Therapy Manufacturing Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Cell Therapy Manufacturing Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Cell Therapy Manufacturing Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Cell Therapy Manufacturing Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Autologous Cell Therapy Manufacturing Services Market Size by Players
3.3.2 Allogeneic Cell Therapy Manufacturing Services Market Size by Players
3.4 Global Cell Therapy Manufacturing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Cell Therapy Manufacturing Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Cell Therapy Manufacturing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Cell Therapy Manufacturing Service Market Size by Type (2020-2031)
6.4 North America Cell Therapy Manufacturing Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Cell Therapy Manufacturing Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Cell Therapy Manufacturing Service Market Size by Type (2020-2031)
7.4 Europe Cell Therapy Manufacturing Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Cell Therapy Manufacturing Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Cell Therapy Manufacturing Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Cell Therapy Manufacturing Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Cell Therapy Manufacturing Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Cell Therapy Manufacturing Service Market Size by Type (2020-2031)
9.4 Central and South America Cell Therapy Manufacturing Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Cell Therapy Manufacturing Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Cell Therapy Manufacturing Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Cell Therapy Manufacturing Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Cell Therapy Manufacturing Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Charles River
11.1.1 Charles River Corporation Information
11.1.2 Charles River Business Overview
11.1.3 Charles River Cell Therapy Manufacturing Service Product Features and Attributes
11.1.4 Charles River Cell Therapy Manufacturing Service Revenue and Gross Margin (2020-2025)
11.1.5 Charles River Cell Therapy Manufacturing Service Revenue by Product in 2024
11.1.6 Charles River Cell Therapy Manufacturing Service Revenue by Application in 2024
11.1.7 Charles River Cell Therapy Manufacturing Service Revenue by Geographic Area in 2024
11.1.8 Charles River Cell Therapy Manufacturing Service SWOT Analysis
11.1.9 Charles River Recent Developments
11.2 Lonza
11.2.1 Lonza Corporation Information
11.2.2 Lonza Business Overview
11.2.3 Lonza Cell Therapy Manufacturing Service Product Features and Attributes
11.2.4 Lonza Cell Therapy Manufacturing Service Revenue and Gross Margin (2020-2025)
11.2.5 Lonza Cell Therapy Manufacturing Service Revenue by Product in 2024
11.2.6 Lonza Cell Therapy Manufacturing Service Revenue by Application in 2024
11.2.7 Lonza Cell Therapy Manufacturing Service Revenue by Geographic Area in 2024
11.2.8 Lonza Cell Therapy Manufacturing Service SWOT Analysis
11.2.9 Lonza Recent Developments
11.3 Catalent
11.3.1 Catalent Corporation Information
11.3.2 Catalent Business Overview
11.3.3 Catalent Cell Therapy Manufacturing Service Product Features and Attributes
11.3.4 Catalent Cell Therapy Manufacturing Service Revenue and Gross Margin (2020-2025)
11.3.5 Catalent Cell Therapy Manufacturing Service Revenue by Product in 2024
11.3.6 Catalent Cell Therapy Manufacturing Service Revenue by Application in 2024
11.3.7 Catalent Cell Therapy Manufacturing Service Revenue by Geographic Area in 2024
11.3.8 Catalent Cell Therapy Manufacturing Service SWOT Analysis
11.3.9 Catalent Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Corporation Information
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Cell Therapy Manufacturing Service Product Features and Attributes
11.4.4 Thermo Fisher Scientific Cell Therapy Manufacturing Service Revenue and Gross Margin (2020-2025)
11.4.5 Thermo Fisher Scientific Cell Therapy Manufacturing Service Revenue by Product in 2024
11.4.6 Thermo Fisher Scientific Cell Therapy Manufacturing Service Revenue by Application in 2024
11.4.7 Thermo Fisher Scientific Cell Therapy Manufacturing Service Revenue by Geographic Area in 2024
11.4.8 Thermo Fisher Scientific Cell Therapy Manufacturing Service SWOT Analysis
11.4.9 Thermo Fisher Scientific Recent Developments
11.5 WuXi AppTech
11.5.1 WuXi AppTech Corporation Information
11.5.2 WuXi AppTech Business Overview
11.5.3 WuXi AppTech Cell Therapy Manufacturing Service Product Features and Attributes
11.5.4 WuXi AppTech Cell Therapy Manufacturing Service Revenue and Gross Margin (2020-2025)
11.5.5 WuXi AppTech Cell Therapy Manufacturing Service Revenue by Product in 2024
11.5.6 WuXi AppTech Cell Therapy Manufacturing Service Revenue by Application in 2024
11.5.7 WuXi AppTech Cell Therapy Manufacturing Service Revenue by Geographic Area in 2024
11.5.8 WuXi AppTech Cell Therapy Manufacturing Service SWOT Analysis
11.5.9 WuXi AppTech Recent Developments
11.6 KBI Biopharma
11.6.1 KBI Biopharma Corporation Information
11.6.2 KBI Biopharma Business Overview
11.6.3 KBI Biopharma Cell Therapy Manufacturing Service Product Features and Attributes
11.6.4 KBI Biopharma Cell Therapy Manufacturing Service Revenue and Gross Margin (2020-2025)
11.6.5 KBI Biopharma Recent Developments
11.7 AGC Biologics
11.7.1 AGC Biologics Corporation Information
11.7.2 AGC Biologics Business Overview
11.7.3 AGC Biologics Cell Therapy Manufacturing Service Product Features and Attributes
11.7.4 AGC Biologics Cell Therapy Manufacturing Service Revenue and Gross Margin (2020-2025)
11.7.5 AGC Biologics Recent Developments
11.8 GenScript
11.8.1 GenScript Corporation Information
11.8.2 GenScript Business Overview
11.8.3 GenScript Cell Therapy Manufacturing Service Product Features and Attributes
11.8.4 GenScript Cell Therapy Manufacturing Service Revenue and Gross Margin (2020-2025)
11.8.5 GenScript Recent Developments
11.9 3P Biopharmaceuticals
11.9.1 3P Biopharmaceuticals Corporation Information
11.9.2 3P Biopharmaceuticals Business Overview
11.9.3 3P Biopharmaceuticals Cell Therapy Manufacturing Service Product Features and Attributes
11.9.4 3P Biopharmaceuticals Cell Therapy Manufacturing Service Revenue and Gross Margin (2020-2025)
11.9.5 3P Biopharmaceuticals Recent Developments
11.10 Siegfried
11.10.1 Siegfried Corporation Information
11.10.2 Siegfried Business Overview
11.10.3 Siegfried Cell Therapy Manufacturing Service Product Features and Attributes
11.10.4 Siegfried Cell Therapy Manufacturing Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Minaris Regenerative Medicine
11.11.1 Minaris Regenerative Medicine Corporation Information
11.11.2 Minaris Regenerative Medicine Business Overview
11.11.3 Minaris Regenerative Medicine Cell Therapy Manufacturing Service Product Features and Attributes
11.11.4 Minaris Regenerative Medicine Cell Therapy Manufacturing Service Revenue and Gross Margin (2020-2025)
11.11.5 Minaris Regenerative Medicine Recent Developments
11.12 Bio-Techne
11.12.1 Bio-Techne Corporation Information
11.12.2 Bio-Techne Business Overview
11.12.3 Bio-Techne Cell Therapy Manufacturing Service Product Features and Attributes
11.12.4 Bio-Techne Cell Therapy Manufacturing Service Revenue and Gross Margin (2020-2025)
11.12.5 Bio-Techne Recent Developments
12 Cell Therapy Manufacturing ServiceIndustry Chain Analysis
12.1 Cell Therapy Manufacturing Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Cell Therapy Manufacturing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Cell Therapy Manufacturing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Charles River
Lonza
Catalent
Thermo Fisher Scientific
WuXi AppTech
KBI Biopharma
AGC Biologics
GenScript
3P Biopharmaceuticals
Siegfried
Minaris Regenerative Medicine
Bio-Techne
List of Tables
 Table 1. Global Cell Therapy Manufacturing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Cell Therapy Manufacturing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Cell Therapy Manufacturing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Cell Therapy Manufacturing Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Cell Therapy Manufacturing Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Cell Therapy Manufacturing Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Cell Therapy Manufacturing Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Cell Therapy Manufacturing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Manufacturing Service as of 2024)
 Table 11. Global Cell Therapy Manufacturing Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Cell Therapy Manufacturing Service Companies Headquarters
 Table 13. Global Cell Therapy Manufacturing Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Cell Therapy Manufacturing Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Cell Therapy Manufacturing Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Cell Therapy Manufacturing Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Cell Therapy Manufacturing Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Cell Therapy Manufacturing Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Cell Therapy Manufacturing Service Growth Accelerators and Market Barriers
 Table 25. North America Cell Therapy Manufacturing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Cell Therapy Manufacturing Service Growth Accelerators and Market Barriers
 Table 27. Europe Cell Therapy Manufacturing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Cell Therapy Manufacturing Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Cell Therapy Manufacturing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Cell Therapy Manufacturing Service Investment Opportunities and Key Challenges
 Table 31. Central and South America Cell Therapy Manufacturing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Cell Therapy Manufacturing Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Cell Therapy Manufacturing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Charles River Corporation Information
 Table 35. Charles River Description and Major Businesses
 Table 36. Charles River Product Features and Attributes
 Table 37. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Charles River Revenue Proportion by Product in 2024
 Table 39. Charles River Revenue Proportion by Application in 2024
 Table 40. Charles River Revenue Proportion by Geographic Area in 2024
 Table 41. Charles River Cell Therapy Manufacturing Service SWOT Analysis
 Table 42. Charles River Recent Developments
 Table 43. Lonza Corporation Information
 Table 44. Lonza Description and Major Businesses
 Table 45. Lonza Product Features and Attributes
 Table 46. Lonza Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Lonza Revenue Proportion by Product in 2024
 Table 48. Lonza Revenue Proportion by Application in 2024
 Table 49. Lonza Revenue Proportion by Geographic Area in 2024
 Table 50. Lonza Cell Therapy Manufacturing Service SWOT Analysis
 Table 51. Lonza Recent Developments
 Table 52. Catalent Corporation Information
 Table 53. Catalent Description and Major Businesses
 Table 54. Catalent Product Features and Attributes
 Table 55. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Catalent Revenue Proportion by Product in 2024
 Table 57. Catalent Revenue Proportion by Application in 2024
 Table 58. Catalent Revenue Proportion by Geographic Area in 2024
 Table 59. Catalent Cell Therapy Manufacturing Service SWOT Analysis
 Table 60. Catalent Recent Developments
 Table 61. Thermo Fisher Scientific Corporation Information
 Table 62. Thermo Fisher Scientific Description and Major Businesses
 Table 63. Thermo Fisher Scientific Product Features and Attributes
 Table 64. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Thermo Fisher Scientific Revenue Proportion by Product in 2024
 Table 66. Thermo Fisher Scientific Revenue Proportion by Application in 2024
 Table 67. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
 Table 68. Thermo Fisher Scientific Cell Therapy Manufacturing Service SWOT Analysis
 Table 69. Thermo Fisher Scientific Recent Developments
 Table 70. WuXi AppTech Corporation Information
 Table 71. WuXi AppTech Description and Major Businesses
 Table 72. WuXi AppTech Product Features and Attributes
 Table 73. WuXi AppTech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. WuXi AppTech Revenue Proportion by Product in 2024
 Table 75. WuXi AppTech Revenue Proportion by Application in 2024
 Table 76. WuXi AppTech Revenue Proportion by Geographic Area in 2024
 Table 77. WuXi AppTech Cell Therapy Manufacturing Service SWOT Analysis
 Table 78. WuXi AppTech Recent Developments
 Table 79. KBI Biopharma Corporation Information
 Table 80. KBI Biopharma Description and Major Businesses
 Table 81. KBI Biopharma Product Features and Attributes
 Table 82. KBI Biopharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. KBI Biopharma Recent Developments
 Table 84. AGC Biologics Corporation Information
 Table 85. AGC Biologics Description and Major Businesses
 Table 86. AGC Biologics Product Features and Attributes
 Table 87. AGC Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. AGC Biologics Recent Developments
 Table 89. GenScript Corporation Information
 Table 90. GenScript Description and Major Businesses
 Table 91. GenScript Product Features and Attributes
 Table 92. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. GenScript Recent Developments
 Table 94. 3P Biopharmaceuticals Corporation Information
 Table 95. 3P Biopharmaceuticals Description and Major Businesses
 Table 96. 3P Biopharmaceuticals Product Features and Attributes
 Table 97. 3P Biopharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. 3P Biopharmaceuticals Recent Developments
 Table 99. Siegfried Corporation Information
 Table 100. Siegfried Description and Major Businesses
 Table 101. Siegfried Product Features and Attributes
 Table 102. Siegfried Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Siegfried Recent Developments
 Table 104. Minaris Regenerative Medicine Corporation Information
 Table 105. Minaris Regenerative Medicine Description and Major Businesses
 Table 106. Minaris Regenerative Medicine Product Features and Attributes
 Table 107. Minaris Regenerative Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Minaris Regenerative Medicine Recent Developments
 Table 109. Bio-Techne Corporation Information
 Table 110. Bio-Techne Description and Major Businesses
 Table 111. Bio-Techne Product Features and Attributes
 Table 112. Bio-Techne Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Bio-Techne Recent Developments
 Table 114. Raw Materials Key Suppliers
 Table 115. Distributors List
 Table 116. Market Trends and Market Evolution
 Table 117. Market Drivers and Opportunities
 Table 118. Market Challenges, Risks, and Restraints
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources


List of Figures
 Figure 1. Cell Therapy Manufacturing Service Product Picture
 Figure 2. Global Cell Therapy Manufacturing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Autologous Cell Therapy Manufacturing Services Product Picture
 Figure 4. Allogeneic Cell Therapy Manufacturing Services Product Picture
 Figure 5. Global Cell Therapy Manufacturing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Cancer Treatment
 Figure 7. Regenerative Medicine
 Figure 8. Genetic Disease Treatment
 Figure 9. Others
 Figure 10. Cell Therapy Manufacturing Service Report Years Considered
 Figure 11. Global Cell Therapy Manufacturing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Cell Therapy Manufacturing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Cell Therapy Manufacturing Service Revenue Market Share by Region (2020-2031)
 Figure 15. Global Cell Therapy Manufacturing Service Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Autologous Cell Therapy Manufacturing Services Revenue Market Share by Player in 2024
 Figure 18. Allogeneic Cell Therapy Manufacturing Services Revenue Market Share by Player in 2024
 Figure 19. Global Cell Therapy Manufacturing Service Revenue Market Share by Type (2020-2031)
 Figure 20. Global Cell Therapy Manufacturing Service Revenue Market Share by Application (2020-2031)
 Figure 21. North America Cell Therapy Manufacturing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 22. North America Top 5 Players Cell Therapy Manufacturing Service Revenue (US$ Million) in 2024
 Figure 23. North America Cell Therapy Manufacturing Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 24. North America Cell Therapy Manufacturing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 25. US Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 26. Canada Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 27. Mexico Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 28. Europe Cell Therapy Manufacturing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Europe Top 5 Players Cell Therapy Manufacturing Service Revenue (US$ Million) in 2024
 Figure 30. Europe Cell Therapy Manufacturing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 31. Europe Cell Therapy Manufacturing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 32. Germany Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 33. France Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 34. U.K. Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 35. Italy Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 36. Russia Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Cell Therapy Manufacturing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Top 8 Players Cell Therapy Manufacturing Service Revenue (US$ Million) in 2024
 Figure 39. Asia-Pacific Cell Therapy Manufacturing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Asia-Pacific Cell Therapy Manufacturing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 41. Indonesia Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 42. Japan Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 43. South Korea Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 44. Australia Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 45. India Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 46. Indonesia Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 47. Vietnam Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 48. Malaysia Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 49. Philippines Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 50. Singapore Cell Therapy Manufacturing Service Revenue (2020-2031) & (US$ Million)
 Figure 51. Central and South America Cell Therapy Manufacturing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Central and South America Top 5 Players Cell Therapy Manufacturing Service Revenue (US$ Million) in 2024
 Figure 53. Central and South America Cell Therapy Manufacturing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 54. Central and South America Cell Therapy Manufacturing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Brazil Cell Therapy Manufacturing Service Revenue (2020-2025) & (US$ Million)
 Figure 56. Argentina Cell Therapy Manufacturing Service Revenue (2020-2025) & (US$ Million)
 Figure 57. Middle East and Africa Cell Therapy Manufacturing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 58. Middle East and Africa Top 5 Players Cell Therapy Manufacturing Service Revenue (US$ Million) in 2024
 Figure 59. South America Cell Therapy Manufacturing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 60. Middle East and Africa Cell Therapy Manufacturing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 61. GCC Countries Cell Therapy Manufacturing Service Revenue (2020-2025) & (US$ Million)
 Figure 62. Israel Cell Therapy Manufacturing Service Revenue (2020-2025) & (US$ Million)
 Figure 63. Egypt Cell Therapy Manufacturing Service Revenue (2020-2025) & (US$ Million)
 Figure 64. South Africa Cell Therapy Manufacturing Service Revenue (2020-2025) & (US$ Million)
 Figure 65. Cell Therapy Manufacturing Service Industry Chain Mapping
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Absorbable Fixation System for Hernia Repair Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-29Q19697
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Renal and Biliary Stent System Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-3R17976
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Access and Dissection Devices for Hernia Repair Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-4M20096
Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Smart Health Care Platform Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-22N17612
Mon Oct 13 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions